Latest Breaking News On - Midcap funding - Page 1 : comparemela.com

Form 10-K Xtant Medical Holdings, For: Dec 31

SURMODICS INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)

Item 1.01 Entry into a Definitive Material Agreement. On October 14, 2022, Surmodics, Inc. entered into a secured revolving credit facility and secured term loan facilities pursuant to a. | October 17, 2022

MidCap Increases Medexus Pharmaceuticals' Revolver to $25MM - News

Medexus Pharmaceuticals entered into an amendment to the company’s revolving credit facility with a syndicate of lenders agented by MidCap Funding IV Trust (MidCap). Among other things, the amendment provides for a US$5.0 million increase in MidCap’s revolving loan commitment amount on substantially the same terms provided under the existing.

Medexus and MidCap Agree to Increase in MidCap's Revolving Loan Commitment Amount

Medexus and MidCap Agree to Increase in MidCap's Revolving Loan Commitment Amount Seite 1

29.09.2022 - Medexus’s borrowing capacity under its revolving credit facility increases byUS$5.0 million, from US$20.0 million to US$25.0 million Transaction strengthens Medexus’s balance sheet, providing additional operating liquidity TORONTO and CHICAGO, . Seite 1